Search by Drug Name or NDC
NDC 00054-0176-13 Buprenorphine HCl 2 mg/1 Details
Buprenorphine HCl 2 mg/1
Buprenorphine HCl is a SUBLINGUAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is BUPRENORPHINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Buprenorphine and the combination of buprenorphine and naloxone are used to treat opioid dependence (addiction to opioid drugs, including heroin and narcotic painkillers). Buprenorphine is in a class of medications called opioid partial agonist-antagonists and naloxone is in a class of medications called opioid antagonists. Buprenorphine alone and the combination of buprenorphine and naloxone work to prevent withdrawal symptoms when someone stops taking opioid drugs by producing similar effects to these drugs.
Related Packages: 00054-0176-13Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Buprenorphine Sublingual and Buccal (opioid dependence)
Product Information
| NDC | 00054-0176 |
|---|---|
| Product ID | 0054-0176_befbc7ee-700d-4c0c-9b0d-7c6076b3aec4 |
| Associated GPIs | 65200010100760 |
| GCN Sequence Number | 029312 |
| GCN Sequence Number Description | buprenorphine HCl TAB SUBL 2 MG SUBLINGUAL |
| HIC3 | H3W |
| HIC3 Description | OPIOID WITHDRAWAL THERAPY AGENTS, OPIOID-TYPE |
| GCN | 64672 |
| HICL Sequence Number | 001762 |
| HICL Sequence Number Description | BUPRENORPHINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Buprenorphine HCl |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Buprenorphine HCl |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | SUBLINGUAL |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | mg/1 |
| Substance Name | BUPRENORPHINE HYDROCHLORIDE |
| Labeler Name | Hikma Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA] |
| DEA Schedule | CIII |
| Marketing Category | ANDA |
| Application Number | ANDA078633 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00054-0176-13 (00054017613)
| NDC Package Code | 0054-0176-13 |
|---|---|
| Billing NDC | 00054017613 |
| Package | 30 TABLET in 1 BOTTLE (0054-0176-13) |
| Marketing Start Date | 2009-10-08 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.44911 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | BUPRENORPHINE 2 MG TABLET SL |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis